Hemo-Monitor NBM200/MP

· OrSense, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hemo-Monitor NBM200/MP, covering 2013-08-06 to 2013-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP